BDMD
Baird Medical·NASDAQ
--
--(--)
--
--(--)
BDMD fundamentals
During H1 2025, Baird Medical (BDMD) reported revenue of 7.96M, a YoY change of -39.41%. Net income was -11.36M, a YoY change of -359.63%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q1,2021 | H1,2021 | 9M,2021 | FY,2021 | Q1,2022 | H1,2022 | 9M,2022 | FY,2022 | Q1,2023 | H1,2023 | 9M,2023 | FY,2023 | Q1,2024 | H1,2024 | FY,2024 | H1,2025 | TTM |
|---|
Start Date | Mar 15, 2021 | Mar 15, 2021 | Mar 15, 2021 | Mar 15, 2021 | Jan 1, 2022 | Jan 1, 2022 | Jan 1, 2022 | Jan 1, 2022 | Jan 1, 2023 | Jan 1, 2023 | Jan 1, 2023 | Jan 1, 2023 | Jan 1, 2024 | Jan 1, 2024 | Jan 1, 2024 | Jan 1, 2025 | -- |
End Date | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Dec 31, 2024 | Jun 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 35.09M -- | -- -- | -- -- | -- -- | 31.46M -10.35% | -- -- | 13.14M -- | 37.04M +17.74% | 7.96M -39.41% | 31.86M -- |
Sales and Services Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 35.09M -- | -- -- | -- -- | -- -- | 31.46M -10.35% | -- -- | 13.14M -- | 37.04M +17.74% | 7.96M -39.41% | 31.86M -- |
Cost of Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 7.05M -- | -- -- | -- -- | -- -- | 4.23M -40.07% | -- -- | 1.65M -- | 4.38M +3.69% | 1.42M -13.45% | 4.16M -- |
Cost of Goods and Services | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 7.05M -- | -- -- | -- -- | -- -- | 4.23M -40.07% | -- -- | 1.65M -- | 4.38M +3.69% | 1.42M -13.45% | 4.16M -- |
Gross Profit | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 28.04M -- | -- -- | -- -- | -- -- | 27.23M -2.88% | -- -- | 11.49M -- | 32.65M +19.92% | 6.54M -43.13% | 27.70M -- |
Operating Expenses | 5.00K -- | 117.62K -- | 230.15K -- | 706.66K -- | 496.78K +9835.58% | 896.05K +661.82% | 1.37M +494.94% | 14.41M +1938.49% | 507.96K +2.25% | 3.98M +344.67% | 6.22M +354.00% | 15.37M +6.69% | 1.82M +258.82% | 6.40M +60.67% | 17.34M +12.82% | 16.99M +165.32% | 27.92M -- |
Selling, General and Administrative Expenses | 5.00K -- | 117.62K -- | 230.15K -- | 706.66K -- | 496.78K +9835.58% | 508.67K +332.47% | 788.97K +242.81% | 10.55M +1392.34% | 457.96K -7.81% | 3.88M +663.33% | 5.97M +657.30% | 11.09M +5.20% | 1.77M +287.08% | 4.37M +12.66% | 11.16M +0.64% | 9.81M +124.15% | 16.60M -- |
Selling and Marketing Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 3.59M -- | -- -- | -- -- | -- -- | 2.55M -28.96% | -- -- | 1.17M -- | 4.06M +59.45% | 1.13M -3.50% | 4.02M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | 189.71K -- | -- -- | -- -- | -- -- | 6.96M +3569.17% | -- -- | 3.82M -- | -- -- | 8.55M +22.79% | -- -- | 3.21M -16.14% | 7.10M -16.89% | 8.68M +170.68% | 12.58M -- |
Research and Development Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 3.86M -- | -- -- | -- -- | -- -- | 4.27M +10.77% | -- -- | 2.03M -- | 6.17M +44.43% | 7.18M +254.16% | 11.33M -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | 387.38K -- | 580.29K -- | -- -- | 50.00K -- | 101.62K -73.77% | 241.62K -58.36% | -- -- | 50.00K -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -5.00K -- | -117.62K -- | -230.15K -- | -706.66K -- | -496.78K -9835.58% | -896.05K -661.82% | -1.37M -494.94% | 13.63M +2029.04% | -507.96K -2.25% | -3.98M -344.67% | -6.22M -354.00% | 11.86M -12.98% | -1.82M -258.82% | 5.09M +227.73% | 15.32M +29.11% | -10.45M -305.35% | -224.53K -- |
Non-Operating Income (Loss) | -- -- | -- -- | -- -- | 9.69K -- | 30.46K -- | 150.61K -- | 1.23M -- | 890.15K +9090.08% | 2.52M +8176.42% | 3.90M +2487.96% | 4.56M +270.88% | 497.48K -44.11% | 253.18K -89.96% | -232.76K -105.97% | -1.23M -346.80% | -349.59K -50.19% | -1.34M -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | 9.69K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | -- -- | 30.46K -- | 150.61K -- | 1.23M -- | 1.18M -- | 2.52M +8176.42% | 3.90M +2487.96% | 4.56M +270.88% | 781.75K -33.80% | 253.18K -89.96% | 5.89K -99.85% | -651.39K -183.32% | 7.86K +33.42% | -649.42K -- |
Net Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 290.72K -- | -- -- | -- -- | -- -- | 284.27K -2.22% | -- -- | 238.66K -- | 576.36K +102.75% | 357.45K +49.78% | 695.16K -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 299.27K -- | -- -- | -- -- | -- -- | 285.83K -4.49% | -- -- | 238.92K -- | 576.75K +101.78% | 358.21K +49.93% | 696.05K -- |
Interest Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 8.55K -- | -- -- | -- -- | -- -- | 1.56K -81.74% | -- -- | 264 -- | 393 -74.84% | 762 +188.64% | 891 -- |
Pretax Income From Continuing Operations | -5.00K -- | -117.62K -- | -230.15K -- | -696.97K -- | -466.31K -9226.30% | -745.44K -533.77% | -140.01K +39.17% | 14.52M +2183.57% | 2.01M +531.76% | -86.72K +88.37% | -1.66M -1083.79% | 12.36M -14.89% | -1.57M -177.95% | 4.86M +5699.97% | 14.09M +13.98% | -10.80M -322.39% | -1.57M -- |
Income Tax Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 200.90K -- | 1.75M -- | 518.98K -- | 797.18K -- | 925.57K +360.72% | 1.70M -2.63% | 46.57K -91.03% | 481.28K -39.63% | 1.49M -12.45% | 559.13K +16.18% | 1.57M -- |
Current Income Tax | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 1.89M -- | -- -- | -- -- | -- -- | 2.24M +18.66% | -- -- | 464.07K -- | 1.46M -35.07% | 556.21K +19.86% | 1.55M -- |
Deferred Income Tax | -- -- | -- -- | -- -- | -146.36K -- | -- -- | -- -- | -- -- | -143.32K +2.08% | -- -- | -- -- | -- -- | -541.99K -278.17% | -- -- | 17.21K -- | 32.77K +106.05% | 2.92K -83.02% | 18.48K -- |
Income Tax Adjustments | -- -- | -- -- | -- -- | 146.36K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -5.00K -- | -117.62K -- | -230.15K -- | -696.97K -- | -466.31K -9226.30% | -745.44K -533.77% | -340.90K -48.12% | 12.77M +1932.93% | 1.49M +420.47% | -883.90K -18.57% | -2.58M -657.68% | 10.66M -16.57% | -1.62M -208.14% | 4.38M +594.98% | 12.60M +18.20% | -11.36M -359.63% | -3.14M -- |
Net Income Attributable to Minority Interests | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 206.22K -- | -- -- | -- -- | -- -- | 112.20K -45.59% | -- -- | 44.86K -- | 144.73K +28.99% | -65.23K -245.41% | 34.64K -- |
Net Income Attributable to Owners of the Company | -5.00K -- | -117.62K -- | -230.15K -- | -696.97K -- | -466.31K -9226.30% | -745.44K -533.77% | -340.90K -48.12% | 12.57M +1903.34% | 1.49M +420.47% | -883.90K -18.57% | -2.58M -657.68% | 10.55M -16.09% | -1.62M -208.14% | 4.33M +589.90% | 12.45M +18.09% | -11.29M -360.81% | -3.17M -- |
Net Income Attributable to Common Stockholders | -5.00K -- | -117.62K -- | -230.15K -- | -696.97K -- | -466.31K -9226.30% | -745.44K -533.77% | -340.90K -48.12% | 12.57M +1903.34% | 1.49M +420.47% | -883.90K -18.57% | -2.58M -657.68% | 10.55M -16.09% | -1.62M -208.14% | 4.33M +589.90% | 12.45M +18.09% | -11.29M -360.81% | -3.17M -- |
Other Comprehensive Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.51M -- | -- -- | -- -- | -- -- | -728.69K +51.64% | -- -- | -828.73K -- | -1.14M -55.89% | 893.94K +207.87% | 586.73K -- |
Total Comprehensive Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 11.27M -- | -- -- | -- -- | -- -- | 9.93M -11.88% | -- -- | 3.55M -- | 11.46M +15.44% | -10.47M -395.09% | -2.55M -- |
Total Comprehensive Income Attributable to Minority Interests | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 206.22K -- | -- -- | -- -- | -- -- | 112.20K -45.59% | -- -- | 44.86K -- | 144.73K +28.99% | -65.23K -245.41% | 34.64K -- |
Total Comprehensive Income Attributable to Owners of the Company | -- -- | -- -- | -- -- | -696.97K -- | -- -- | -- -- | -- -- | 11.06M +1687.13% | -- -- | -883.90K -- | -- -- | 9.82M -11.25% | -- -- | 3.50M +496.14% | 11.32M +15.28% | -10.40M -397.01% | -2.58M -- |
Basic EPS | 0 -- | 0 -- | 0 -- | -0.07 -- | -0.02 -- | -0.03 -- | -0.01 -- | 0.49 +800.00% | 0.05 +350.00% | -0.04 -33.33% | -0.15 -1400.00% | 0.41 -16.33% | -0.2 -500.00% | 0.17 +525.00% | 0.49 +19.51% | -0.43 -352.94% | -0.11 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -0.07 -- | -- -- | -- -- | -- -- | 0.49 +800.00% | -- -- | -0.04 -- | -- -- | 0.41 -16.33% | -- -- | 0.17 +525.00% | 0.49 +19.51% | -0.43 -352.94% | -0.11 -- |
Diluted EPS | 0 -- | 0 -- | 0 -- | -0.07 -- | -0.02 -- | -0.03 -- | -0.01 -- | 0.49 +800.00% | 0.05 +350.00% | -0.04 -33.33% | -0.15 -1400.00% | 0.41 -16.33% | -0.2 -500.00% | 0.17 +525.00% | 0.49 +19.51% | -0.43 -352.94% | -0.11 -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -0.07 -- | -- -- | -- -- | -- -- | 0.49 +800.00% | -- -- | -0.04 -- | -- -- | 0.41 -16.33% | -- -- | 0.17 +525.00% | 0.49 +19.51% | -0.43 -352.94% | -0.11 -- |
You can ask Aime
What were the key takeaways from Baird Medical's earnings call?What is the revenue and EPS growth rate for Baird Medical year over year?What were the key takeaways from Baird Medical’s earnings call?What is the market's earnings forecast for Baird Medical next quarter?What does Baird Medical do and what are its main business segments?What guidance did Baird Medical's management provide for the next earnings period?What is Baird Medical's gross profit margin?What is Baird Medical's latest dividend and current dividend yield?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
